Theravance Biopharma, Inc. (TBPH)
17.77
-0.40
(-2.20%)
USD |
NASDAQ |
Dec 15, 16:00
17.78
+0.02
(+0.08%)
After-Hours: 20:00
Theravance Biopharma Research and Development Expense (TTM): 37.97M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Corcept Therapeutics, Inc. | 260.35M |
| Assertio Holdings, Inc. | 2.49M |
| Skye Bioscience, Inc. | 38.14M |
| FibroGen, Inc. | 23.12M |
| VYNE Therapeutics, Inc. | 25.94M |